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high CRP level (tertile 3). Results: Plasma fetuin-A and CRP concentrations at
admission averaged 95±27mg/L and 11±16UI, respectively with low fetuin-A
defined as <69mg/L and high CRP level as 25UI. At one year follow up
(n=726, 97%), cardiovascular mortality (n=50, 7%) was 16% (18/111), 9%
(21/250) and 3% (11/365) in patients with low fetuin-A/high CRP (n=111),
either low fetuin or high CRP (n=250) and high fetuin-A/low CRP (n=365),
respectively. By multivaritate analysis low fetuin-A/high CRP level remained
independently predictive of outcome (OR=3.4 [1.6-7.3], p=0.001, Figure 1)
after adjustment to ST elevation, GRACE score and medical treatment. In con-




 Inflammatory imbalance assessed by combining fetuin-A and




Impact of type of pre-admission sulfonylureas on mortality and car-
diovascular outcomes in diabetic patients with acute myocardial
infarction
Marianne Zeller (1), Nicolas Danchin (2), Dominique Simon (3), Alec Vaha-
nian (4), Luc Lorgis (5), Yves Cottin (5), Jascques Berland (6), Pascal Gueret
(7), Pascal Wyart (8), Régis Deturck (9), Xavier Tabone (10), Jacques Mache-
court (11), Florence Leclercq (12), Elodie Drouet (13), Genevieve Mulak (13),
Jean Pierre Cambou (13), Jean Ferrieres (14), Tabassome Simon (15)
(1) IFR 100 santé-STIC, LPPCE, Dijon, France – (2) Hôpital Européen
Georges Pompidou Université René-Descartes, Cardiologie, Paris, France –
(3) CHU Pitié-Salpêtrière, Diabetologie, Paris, France – (4) CHU Bichat-
Claude Bernard, Cardiologie, Paris, France – (5) CHU Bocage, Cardiologie,
Dijon, France – (6) Clinique St Hilaire, Rouen, France – (7) CHU Mondor,
Cardiologie, Créteil, France – (8) Hôpital de Villeneuve St Georges, Cardio-
logie, Paris, France – (9) CHG, Cardiologie, Lens, France – (10) CHG,
Bourges, France – (11) CHU, Grenoble, France – (12) CHU, Cardiologie,
Montpellier, France – (13) Société Française de Cardiologie, Paris, France –
(14) CHU, Cardiologie, Toulouse, France – (15) CHU Saint Antoine-
URCEST, Université Pierre et Marie Curie, Paris-VI, France
Background:
 
 the impact of antidiabetic medications on clinical outcomes
in patients developing acute myocardial infarction (MI) is controversial. We
sought to determine whether in-hospital outcomes in patients who were on sul-
fonylureas (SUs) when they developed their MIs differed from those of dia-
betic patients not receiving SUs, and whether clinical outcomes were related




 we analyzed the outcomes of the 1310 diabetic patients
included in the nationwide French registry of Acute ST-elevation and non ST-ele-
vation myocardial infarction (FAST-MI) in 2005. Medications used before the
acute episode were recorded. In-hospital complications were analyzed according to
prior antidiabetic treatment. Mortality was lower in patients previously treated with
SUs (3.9%), versus those on other oral medications (6.4%), insulin (9.4%) or no
medication (8.4%) (p=0.014). Among SU-treated patients, in-hospital mortality
was lower in patients receiving pancreatic cell-specific SUs (gliclazide or glime-
piride)(2.7%), compared with those on glibenclamide (7.5%) (p=0.019). Arrhyth-
mias and ischemic complications were also less frequent in patients receiving
gliclazide/glimepiride. The lower risk in patients receiving gliclazide/glimepiride
versus glibenclamide persisted after multivariate adjustment (OR=0.15; 95%CI:




 In this nationwide registry of patients hospitalized for acute
MI, no hazard was associated with the use of SUs before the acute episode. In
addition, patients who had previously received gliclazide/glimepiride had
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Background:
 
 In patients with acute myocardial infarction (MI), beta-bloc-
kers are recommended and contribute to control the heart rate (HR). The fac-
tors associated with HR and outcome of patients discharged with HR>70 beats




 Prospective registry including patients with acute MI. Recorded
variables corresponded to the CARDS dataset. The proportion of patients dis-
charged with HR>70 bpm was assessed. Multivariate regression was used to deter-
mine factors associated with HR at discharge and logistic regression was used to




 Among the 837 patients, 592 survived and were discharged with




 70 bpm in 61% when a betablocker was
given and in 31% without beta blocker (p<0.001). Discharge HR was asso-
ciated with older age, admission HR, admission systolic blood pressure, BNP
level, diabetes, use of beta blockers and ACEI. Patients discharged with










charge was an independent predictor of 30 day mortality on top of the GRACE




 Among patients discharged after acute MI, those with
HR>70 have higher 30 day mortality, independently of the GRACE risk score
and use of beta blockers.
Mortality by discharge heart rate
